#2017GairdnerAwards, #Canada, #DrAntoineHakim, #DrLewisKay
Two Canadian researchers, Dr. Antoine Hakim, a professor emeritus of neurology at the University of Ottawa and Toronto biomedical scientist Lewis Kay, a senior scientist in molecular medicine at Toronto's Hospital for Sick Children, were among the seven international recipients of 2017 Gairdner Awards announced Tuesday in Toronto, media reports said.
Canadian Stem Cell Foundation posted on the facebook account of Dr. Antoine Hakim, “
Dr. Antoine Hakim, one of Canada’s truly inspirational medical leaders, is this year’s winner of the Gairdner Wightman Award. http://bit.ly/2o7Nmna.”
A post by The Neuro on the face book account of Dr. Antoine Hakim reads, “Dr. Antoine Hakim, a former neurology resident at the MNI, has won the prestigious Gairdner Prize for his development of better treatments for stroke. Dr. Hakim was trained by Dr. Hanna Pappius, a professor in the Department of Neurology and Neurosurgery.”
Hakim was named recipient of the 2017 Canada Gairdner Wightman Award for his outstanding leadership in medicine and medical science, CBCNews reports said.
He pioneered the setting up of Canadian Stroke Network and then partnered with the Heart and Stroke Foundation and other organizations to develop the Canadian Stroke Strategy.
Gairdner Foundation @GairdnerAwards tweeted, “Dr. Antoine Hakim of @OttawaHospital is awarded our 2017 Canada #Gairdner Wightman Award for his powerful leadership and research on stroke.”
1310 NEWSVerified account @1310NEWS tweeted, “Dr. Antoine Hakim @OttawaHospital has just won the 2017 @GairdnerAwards for his work on stroke care and joins the @MeehanCarolAnne show next.”
Kay, was recognized for his work in the field of biomolecular nuclear magnetic resonance (NMR) spectroscopy, and the development of methods which revealed how molecules involved in neurodegeneration can form abnormal structures that ultimately lead to disease. Kay's methods are being used in labs all across the world and by researchers of diabetes, cancer and cardiovascular disease.
Gairdner Foundation @GairdnerAwards tweeted, “Dr. Rossant congratulates Dr. Lewis Kay @SickKidsNews @UofTNews who receives our 2017 Canada #Gairdner Int'l Award. 1st Canadian since '08.”
The Gairdners, nicknamed the "baby Nobels" because 84 winners have gone on to win Nobel Prizes in physiology or medicine, each carry a $100,000 honorarium and will be presented at a gala dinner on Oct. 26.
The four other recipients of a Canada Gairdner International Award were:
Dr. Akira Endo, president of Biopharm Research Laboratories and professor emeritus at the Tokyo University of Agriculture and Technology, for the discovery and development of statins that have transformed the prevention and treatment of cardiovascular disease.
Dr. David Julius, chair of physiology and also molecular biology and medicine at the University of California at San Francisco, for determining the molecular basis of somatosensation and the role of how people sense heat, cold and pain can play in chronic pain.
Dr. Rino Rappuoli, chief scientist and head of external R&D at GSK Vaccines in Siena, Italy. His work led to the licensing of the first meningococcus B vaccine approved in Europe and Canada in 2013 and in the U.S. in 2015.
Dr. Huda Zoghbi, director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital in Houston, for the discovery of the genetic basis of Rett syndrome and its implications for autism spectrum disorders. Her discovery of the Rett syndrome gene provided a diagnostic test that allows for early diagnosis.
2017 John Dirks Canada Gairdner Global Health Award went to Dr. Cesar Victora, professor emeritus at the Federal University of Pelotas in Brazil, for a scientific advancement on health in the developing world with particular focus on exclusive breastfeeding on infant mortality and on the long-term impact of early-life nutrition.
(Reporting by Asha Bajaj)